Sharing Lessons Learned After Approval to Drive Gene Therapy Products Towards Approval
Time: 9:00 am
day: Conference Day Two
Details:
- Presenting a case study on the EU and US registration of an ex-vivo LVV-based gene therapy for the treatment of a rare neurodegenerative disease
- Identifying areas for improvement and optimizing efficiency by recommending hurdles to strategically plan for
- Summarizing key lessons learned during the approval process and sharing insights
